Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 75

Sort by

Sort Order Select

Journal Articles

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Veysel Suzan, MD, Nurgul Ozgur Yurttas, MD, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD, Dilek Keskin, MD, Sevil Sadri, MD, Selin Berk, MD, Isil Erdogan, MD, Tugrul Elverdi, MD, Ayse Salihoglu, MD, Muhlis Cem Ar, MD PhD, Zafer Baslar, MD

Blood (2019) 134 (Supplement_1): 4933.

https://doi.org/10.1182/blood-2019-130305

Published: 2019

Journal Articles

Response to First-Line Treatment in Patients with N/K T-Cell Lymphoma. Experience of a Third Level Mexican Institute

Katheryn Betsabe Garzón, MD, Silvia Rivas-Vera, MD, Brenda L. Acosta-Maldonado, MD

Blood (2019) 134 (Supplement_1): 5286.

https://doi.org/10.1182/blood-2019-129887

Published: 2019

Journal Articles

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Berardino Pollio, Maria Messina, Irene Ricca, Mauro Pagliarino, Ugo Ramenghi, MD, Antonio Coppola, Anna Castiglione, Giovannino Ciccone, Teresa Ceglie, Anna Mondino, Paolo Tavormina, Claudia Linari

Blood (2019) 134 (Supplement_1): 2400.

https://doi.org/10.1182/blood-2019-130023

Published: 2019

Journal Articles

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

Shona Philip, BSc, MSc, MD, Christopher Bredeson, MD FRCPC, MSc, David S. Allan, MD FRCPC, MSc, Sultan Altouri, MD FRCPC, Lothar B. Huebsch, MD, Harold Atkins, MD, Natasha Kekre, MD FRCPC

Blood (2018) 132 (Supplement 1): 4624.

https://doi.org/10.1182/blood-2018-99-119797

Published: 2018

Journal Articles

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Sikander Ailawadhi, Abdel-Ghani Azzouqa, Zahara Meghji, Tania Jain, MD, Nancy Diehl, Stephanie P. Gebhardt, Vishal Shah, David O. Hodge, MS, Raj Patel, MD, Prachi Jani, MD, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Rafael Fonseca, MD

Blood (2017) 130 (Supplement 1): 5440.

https://doi.org/10.1182/blood.V130.Suppl_1.5440.5440

Published: 2017

Journal Articles

Effects of the Gamma Secretase Inhibitors (GSI) Dapt (GSI-IX) and LSN424354 on Gene Expression and Shedding of Bcma from Multiple Myeloma and Chronic Lymphocytic Leukemia Tumor Cells

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Camilia Soof, BS, Saurabh Patil, BS, Kyle Udd, BA, Mizi Zhou, MS, Tara Hekmati, BS, Emily Y Wang, Edward J Tanenbaum, BS, Remy Schlossberg, Moryel A Yashar, BS, Cathy S Wang, BS, George Y Tang, PhD, James R Berenson, MD

Blood (2017) 130 (Supplement 1): 5390.

https://doi.org/10.1182/blood.V130.Suppl_1.5390.5390

Published: 2017

Journal Articles

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Bilawal Ahmed, MD, Beenish Zulfiqar, MD

Blood (2017) 130 (Supplement 1): 4757.

https://doi.org/10.1182/blood.V130.Suppl_1.4757.4757

Published: 2017

Journal Articles

Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients

Mark T Drayson, MD PhD, Stella Bowcock, MDMA, Tim Planche, MDPhD, Gulnaz Iqbal, PhD, Jill Wood, MPH, Kerry Raynes, MSc, Guy Pratt, MD FRCP, FRCPath, Kwee Yong, PhD, Peter Hawkey, FRCPath, Helen Higgins, MSc, Janet Dunn, PhD

Blood (2017) 130 (Supplement 1): 903.

https://doi.org/10.1182/blood.V130.Suppl_1.903.903

Published: 2017

Journal Articles

Second Primary Malignancies in Long Term Acute Lymphoblastic Leukemia Survivors of Three Age Groups

Sreya Yalamanchili, Yamini Penikalapati, Nikita Kondapalli, Rakesh Surapaneni, MD

Blood (2017) 130 (Supplement 1): 2568.

https://doi.org/10.1182/blood.V130.Suppl_1.2568.2568

Published: 2017

Journal Articles

Supra-Physiological Concentrations of C1 Esterase Inhibitor Enhance Thrombin Generation in the Presence of Thrombomodulin

Ivan Tarandovskiy, PhD, Paul Buehler, Ph. D., Elena Karnaukhova

Blood (2017) 130 (Supplement 1): 2353.

https://doi.org/10.1182/blood.V130.Suppl_1.2353.2353

Published: 2017

Journal Articles

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

David Kasouha, Nicola Lehners, MD, Katharina Kriegsmann, MD MBA, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig, MD MHBA

Blood (2017) 130 (Supplement 1): 2855.

https://doi.org/10.1182/blood.V130.Suppl_1.2855.2855

Published: 2017

Journal Articles

Results of an Interim Safety Analysis of a Phase 2 Study of Daratumumab (Dara) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) in Previously Untreated and Relapsed Patients (Pts) with Multiple Myeloma (MM)

Habte Yimer, MD, Jason Melear, MD, Edward Faber, William I. Bensinger, MD, John M Burke, MD, Sriya Gunawardena, MD, Murphy Sean, Hollee Parros, Yana Lutska, Mohamed Darif, PhD, Anil Londhe, PhD, Ming Qi, Jon Ukropec, Thomas Lin, Robert M. Rifkin, MD

Blood (2017) 130 (Supplement 1): 1839.

https://doi.org/10.1182/blood.V130.Suppl_1.1839.1839

Published: 2017

Journal Articles

Results of an Ongoing Phase 2 Study of Brentuximab Vedotin with Rchp As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL)

Blood (2016) 128 (22): 104.

https://doi.org/10.1182/blood.V128.22.104.104

Published: 2016

Journal Articles

Prevalence and Eradication of Colonizing Staphylococcus Aureus in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

C. Matthias Wilk, MD, Isabel Weber, Carole Rachmühl, Kati Seidl, PhD, Anne Holzmann Bürgel, Antonia MS Müller, MD, Urs Schanz, MD, Annelies S. Zinkernagel, MD PhD MSc

Blood (2016) 128 (22): 3413.

https://doi.org/10.1182/blood.V128.22.3413.3413

Published: 2016

Journal Articles

The Impact of Colonization with Multidrug-Resistant Bacterial Pathogens (MRP) in Allogeneic Hematopoietic Cell Transplantation - Clearance of the MRP Is Pivotal for Survival

Daniela Heidenreich, Sebastian Kreil, Klaus-Peter Becker, Thomas Miethke, Wolf-Karsten Hofmann, MD, Stefan A. Klein, MD

Blood (2016) 128 (22): 3421.

https://doi.org/10.1182/blood.V128.22.3421.3421

Published: 2016

Journal Articles

Results of an Early Access Treatment Protocol (EAP) of Daratumumab in United States Patients with Relapsed or Refractory Multiple Myeloma

Ajai Chari, MD, Tomer M Mark, MD MSc, Amrita Krishnan, Keith Stockerl-Goldstein, Saad Z Usmani, MD FACP, Anil Londhe, Delores Etheredge, Hollee Parros, Sarah Fleming, Baolian Liu, Scott Freeman, Jon Ukropec, PhD, Thomas Lin, Sagar Lonial, MD FACP

Blood (2016) 128 (22): 2133.

https://doi.org/10.1182/blood.V128.22.2133.2133

Published: 2016

Journal Articles

Use of Montelukast to Reduce Infusion Reactions in an Early Access Treatment Protocol of Daratumumab in United States Patients with Relapsed or Refractory Multiple Myeloma

Blood (2016) 128 (22): 2142.

https://doi.org/10.1182/blood.V128.22.2142.2142

Published: 2016

Journal Articles

CNS Relapse in Diffuse Large B-Cell Lymphoma Patients with Oral Cavity and Bone Marrow Involvement-Experience from an Inner City Hospital

Surabhi Pathak, MBBS, Romy Jose Thekkekara, MBBS, Jibran Ahmed, MD MBBS, Paula Kovarik, MD, Rosalind Catchatourian, MD

Blood (2016) 128 (22): 5409.

https://doi.org/10.1182/blood.V128.22.5409.5409

Published: 2016

Journal Articles

Gene Expression of Gamma Secretase (GS) Complex-Related Proteins, the Enzyme That Sheds B-Cell Maturation Antigen (BCMA), Among Patients with Multiple Myeloma (MM) and Effects of the GS Inhibitor LSN424354 on Solubilized Bcma in MM and Chronic Lymphocytic Leukemia

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Cathy S Wang, BS, Kyle A Udd, BA, Camilia M Soof, BS, Christian E Casas, BS, Jessica Wang, MS, Jasmin Cao, Kevin DeCorso, Tara Hekmati, George Tang, PhD, James R. Berenson, MD

Blood (2016) 128 (22): 5641.

https://doi.org/10.1182/blood.V128.22.5641.5641

Published: 2016

Journal Articles

Retrospective Analysis of Seasonal Respiratory Viral Infections (SRVI) in Hematology, Lymphoma and Oncology Patients

Samar Kulkarni, MD MRCP, FRCPath, Stephanie Michail, MBBS, Charlotte Smith, MSc, Joanna Tomlins, MSc, John Murray, BSc (hons), MSc, Michael Dennis, FRCPath, Jim Cavet, FRCPath, Tim Somervaille, MD PhD, Daniel Wiseman, FRCPath, Anna Z Castleton, FRCPath, Adrian Bloor

Blood (2016) 128 (22): 4608.

https://doi.org/10.1182/blood.V128.22.4608.4608

Published: 2016

NARROW

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Response to First-Line Treatment in Patients with N/K T-Cell Lymphoma. Experience of a Third Level Mexican Institute

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Effects of the Gamma Secretase Inhibitors (GSI) Dapt (GSI-IX) and LSN424354 on Gene Expression and Shedding of Bcma from Multiple Myeloma and Chronic Lymphocytic Leukemia Tumor Cells

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients

Second Primary Malignancies in Long Term Acute Lymphoblastic Leukemia Survivors of Three Age Groups

Supra-Physiological Concentrations of C1 Esterase Inhibitor Enhance Thrombin Generation in the Presence of Thrombomodulin

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Results of an Interim Safety Analysis of a Phase 2 Study of Daratumumab (Dara) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) in Previously Untreated and Relapsed Patients (Pts) with Multiple Myeloma (MM)

Results of an Ongoing Phase 2 Study of Brentuximab Vedotin with Rchp As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL)

Prevalence and Eradication of Colonizing Staphylococcus Aureus in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

The Impact of Colonization with Multidrug-Resistant Bacterial Pathogens (MRP) in Allogeneic Hematopoietic Cell Transplantation - Clearance of the MRP Is Pivotal for Survival

Results of an Early Access Treatment Protocol (EAP) of Daratumumab in United States Patients with Relapsed or Refractory Multiple Myeloma

Use of Montelukast to Reduce Infusion Reactions in an Early Access Treatment Protocol of Daratumumab in United States Patients with Relapsed or Refractory Multiple Myeloma

CNS Relapse in Diffuse Large B-Cell Lymphoma Patients with Oral Cavity and Bone Marrow Involvement-Experience from an Inner City Hospital

Gene Expression of Gamma Secretase (GS) Complex-Related Proteins, the Enzyme That Sheds B-Cell Maturation Antigen (BCMA), Among Patients with Multiple Myeloma (MM) and Effects of the GS Inhibitor LSN424354 on Solubilized Bcma in MM and Chronic Lymphocytic Leukemia

Retrospective Analysis of Seasonal Respiratory Viral Infections (SRVI) in Hematology, Lymphoma and Oncology Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only